# PCORI Scraped Content

## Raw Content from PCORI Funding Pages

---

## Source: PCORI Funding Opportunities Main Page

**URL:** https://www.pcori.org/funding-opportunities
**Retrieved:** February 2, 2026

### Current Funding Announcements (Open Status)

Three engagement awards are currently open with deadlines of March 30, 2026 (LOI) and July 13, 2026 (application):
- Engagement Award: Capacity Building
- Engagement Award: Dissemination Initiative
- Engagement Award: Convening Support

### Upcoming Opportunities (Opening April 1, 2026)

Six research funding announcements will open April 1, 2026, with LOI deadline April 28 and application deadline September 1:

1. **Addressing Sensory Health Needs Across the Lifespan** - Research
2. **Broad Pragmatic Studies** - Research
3. **Phased Large Awards for Comparative Effectiveness Research** - Research
4. **Advancing the Science of Engagement in Research** - Research
5. **Improving Methods for Conducting Patient-Centered Comparative Clinical Effectiveness Research** - Research
6. **PCORI Call for Proposals for HSII Implementation Projects** - Health Systems Implementation Initiative

### Letters of Intent Under Review

Seven announcements have LOIs currently under review from Cycle 1 2026, including:
- Cancer Partner PFA (research focused on cancer care continuum)
- Observational studies leveraging existing data sources
- Broad Pragmatic Studies
- Phased Large Awards for Comparative Effectiveness Research
- Methods improvement research
- Implementation awards

---

## Source: Broad Pragmatic Studies PFA - Cycle 1 2026

**URL:** https://www.pcori.org/funding-opportunities/announcement/broad-pragmatic-studies-pcori-funding-announcement-cycle-1-2026
**Retrieved:** February 2, 2026

### Program Description

PCORI invites applications for "high-impact patient-centered comparative clinical effectiveness research (CER) projects." The program supports individual or cluster randomized controlled trials, natural experiments, and observational studies focused on clinically meaningful outcomes important to patients.

### Award Categories and Amounts

| Category | Direct Costs | Details |
|----------|-------------|---------|
| **Category 1** | Up to $5 million | Standard pragmatic research projects |
| **Category 2** | $5-$12 million | Requires justification for larger scope and resources |
| **Category 3** | Up to $12 million | PCORnet-based observational studies/trials at national scale |

**Total Available Funding:** Approximately $120 million across all categories

**Project Period:** Up to 5 years for all categories

### Key Dates

- **Application System Opens:** December 2, 2025
- **Applicant Town Hall:** December 8, 2025
- **Letter of Intent Deadline:** January 6, 2026 (5 pm ET)
- **LOI Status Notification:** February 3, 2026
- **Full Application Deadline:** May 5, 2026 (5 pm ET)
- **Merit Review:** July 2026
- **Awards Announced:** December 2026
- **Earliest Start Date:** April 2027

### Research Design Requirements

Applicants must propose studies with:
- Adequate sample sizes for precise effect estimation and heterogeneity analysis
- "Well-justified and validated outcomes that are clinically meaningful and considered important by patients"
- Consideration of hybrid effectiveness-implementation approaches (though strict implementation studies are not eligible)
- Full range of clinical and patient-centered outcome data

**Ineligible studies:** Those focused solely on method development or dissemination without effectiveness components.

### Special Areas of Emphasis (SAEs)

1. **Obesity Treatment & Management**
   - Comparing lifestyle, anti-obesity medications, endoscopic procedures, bariatric surgery, and combinations
   - Objective, clinically meaningful primary outcomes preferred

2. **Menopausal Symptoms**
   - Hormonal and non-hormonal pharmacologic interventions
   - Non-pharmacologic treatments
   - Health-system or community-level interventions
   - Special interest in early menopause, surgically-induced menopause, and breast cancer survivors

3. **Care Delivery for Intellectual and Developmental Disabilities (IDD)**
   - Systems-level strategies improving access, quality, and care navigation
   - Focus on quality of life, community participation, and healthcare utilization

### Patient Engagement Requirements

PCORI mandates "meaningful patient and partner engagement as a component of the research that it funds." Applicants must address PCORI's Foundational Expectations for Partnerships in Research, which include:
- Systematic frameworks for patient and stakeholder engagement
- Flexibility in implementation approaches
- Integration throughout project development and execution

### PCORnet Category 3 Requirements

Category 3 studies must:
- Utilize PCORnet's clinical research infrastructure
- Include "two or more Clinical Research Networks"
- Conduct national-scale observational studies or pragmatic trials
- Leverage the PCORnet Common Data Model
- Share "study progress, performance metrics and best practices with the network"

### Coverage of Patient Care Costs

Applicants may request coverage of patient care costs, subject to PCORI's criteria. Funding is not guaranteed.

### Structured Mentorship Support

Projects may propose structured mentorship for early/mid-career investigators, those transitioning to patient-centered CER, and patient/community partners. Funding contingent on meeting specified criteria.

### Application Deferral Policy

Applicants invited to submit full applications may defer once to the next PFA cycle, potentially crossing years.

### Application Components Required

Mandatory templates include:
- Letter of Intent
- Research Plan
- Letters of Support Table
- Milestones Template
- Methodology Standards Checklist
- Budget Justification
- Subcontractor Budget (if applicable)
- Leadership Plan (if dual-PI)
- Scientific PI & Key Personnel documentation
- Patient/Stakeholder Partner documentation
- Project/Performance Sites documentation
- Resubmission Letter (if applicable)

---

## Source: PLACER PFA - Cycle 1 2026

**URL:** https://www.pcori.org/funding-opportunities/announcement/phased-large-awards-comparative-effectiveness-research-pcori-funding-announcement-cycle-1-2026
**Retrieved:** February 2, 2026

### Program Description

PCORI invites applications for "high impact patient-centered comparative clinical effectiveness research (CER) projects" addressing critical healthcare decisions where evidence is insufficient. The program requires individual-level or cluster randomized controlled trials of significant scale comparing interventions already in current use with established efficacy.

### Award Amounts & Budget

- **Total Available Funds:** $120 million
- **Maximum per Project:** $22 million direct costs total
  - Feasibility phase: $2 million (18 months)
  - Full-scale phase: $20 million (5 years)
- **Minimum Expected:** Budgets "will require funding in excess of $12 million in direct costs"

### Phased Structure Requirements

The funding operates in two phases:

**Feasibility Phase:** Supports "study refinement, infrastructure establishment, patient and stakeholder engagement, and testing of study operations, including the ability to recruit, enroll, and randomize participants successfully." Establishing intervention efficacy is prohibited during this phase.

**Full-Scale Phase:** Contingent on achieving specific milestones and deliverables from the feasibility phase.

### Data Coordinating Center Requirements

PCORI mandates "shared trial leadership by a data coordinating center to provide an independent role in study leadership, advising on the analytical, statistical and data management aspects of both study phases."

### Application Deadlines

- **Letter of Intent:** January 6, 2026 (5 PM ET)
- **LOI Status Notification:** February 3, 2026
- **Full Application:** May 5, 2026 (5 PM ET)
- **Awards Announced:** December 2026
- **Earliest Start:** April 2027

### Patient Engagement Requirements

"Meaningful patient and stakeholder engagement is viewed as an essential component of funded PLACER studies." Applicants must address PCORI's Foundational Expectations framework, employing "multiple approaches that occur along a continuum of engagement from input to shared leadership."

### Additional Features

- **Coverage:** Patient care costs may be requested (approval not guaranteed)
- **Deferral Policy:** One allowed deferral to the next PFA cycle
- **Topics:** Applicants may select up to three research project agenda themes or indicate "N/A"

---

## Source: Methods PFA - Cycle 1 2026

**URL:** https://www.pcori.org/funding-opportunities/announcement/improving-methods-conducting-patient-centered-comparative-clinical-effectiveness-research-pcori-funding-announcement-cycle-1-2026
**Retrieved:** February 2, 2026

### AI/ML Priority Areas

PCORI emphasizes "Methods to Improve the Use of Artificial Intelligence (AI) and Machine Learning (ML) in Clinical Research" as a key methodological gap requiring attention.

### Financial Parameters

- **Total Available:** Up to $12 million across all awards
- **Per-Project Maximum:** Up to $750,000 in direct costs
- **Project Duration:** Up to three years

### Critical Timeline

| Milestone | Date |
|-----------|------|
| LOI Deadline | January 6, 2026, 5 pm ET |
| LOI Status Notification | February 3, 2026 |
| Full Application Deadline | May 5, 2026, 5 pm ET |
| Merit Review | July 2026 |
| Awards Announced | December 2026 |
| Earliest Start Date | April 2027 |

### Four Priority Topic Areas

1. Methods to Improve AI/ML Use in Clinical Research
2. Methods to Improve Study Design
3. Methods to Support Data Research Networks
4. Methods Related to Ethical and Human Subjects Protections

### Application Requirements

- Submit Letter of Intent (using provided template)
- Complete Research Plan using PCORI template
- Demonstrate meaningful patient/stakeholder engagement per "PCORI's Foundational Expectations"
- Include milestones, budget justification, and key personnel documentation

---

## Source: PCORI Foundational Expectations

**URL:** https://www.pcori.org/engagement-research/engagement-resources/foundational-expectations
**Retrieved:** February 2, 2026

### The Six Foundational Expectations

1. **Representative Involvement:** Projects should incorporate "partners, organizations, researchers, and other team members who reflect the range of patients and communities affected by the research topic."

2. **Early & Ongoing Engagement:** Teams must ensure "partners contribute early and throughout the study, including planning the study, conducting the study, and disseminating study results."

3. **Dedicated Funds for Engagement & Partner Compensation:** Resources should support engagement activities and "compensate partners for their time, expertise & perspectives in a timely manner and in ways that reflect their preferences & role."

4. **Build Capacity to Work as a Team:** Organizations should "identify skills, strengths and barriers to engagement" and furnish team members with necessary information, training, and support for collaborative work.

5. **Meaningful Inclusion of Partners in Decision Making:** Teams must implement "engagement structures and processes that include partners in decision making throughout all phases of the project."

6. **Ongoing Review & Assessment of Engagement:** Projects should "gather input and feedback throughout the project to identify what is working well and what could be improved, and then adjust engagement approaches as needed."

### Meaningful Engagement Definition

The document specifies that engagement must involve "active partnership" progressing beyond simple input to include consultation, collaboration, and shared leadership roles.

---

## Source: PCORI Merit Review

**URL:** https://www.pcori.org/funding-opportunities/merit-review
**Retrieved:** February 2, 2026

### Process Stages

The merit review involves "a multi-phase process that includes an external review panel's preliminary online review of full applications and an in-panel discussion of a subset of applications."

### Reviewer Composition

PCORI's review process is "distinguished by the participation of scientists, patients, and other stakeholders," enabling identification of "high-quality, scientifically rigorous, and patient-centered studies."

### Post-Review Steps

After merit review, the process includes "post-panel review of application by PCORI staff, Selection Committee recommendation of applications for funding, and award approval by PCORI's Executive Director."

### Scoring System

- **Scale:** 9-point scale
- **Scores 7-9:** Applications with major weaknesses
- **Scores 1-3:** Applications with minor weaknesses
- Reviewers are asked to utilize the whole scoring range

### Panel Composition

Merit Review Panels consist of scientific, patient, and other stakeholder reviewers whose scores are equally weighted to ensure that all perspectives are heard.

---

## Source: PCORI LOI Tips

**URL:** https://www.pcori.org/blog/2023/tips-writing-responsive-letter-intent-research-awards
**Retrieved:** February 2, 2026

### Required LOI Components

According to the PFA template, LOIs must include:
- Research question and background
- Study population and research settings
- Comparators being tested
- Outcomes to be measured
- Study design approach
- Sample size, power, and analytical plan
- Engagement strategy
- PI and team qualifications
- Project duration and costs
- References

### Key Writing Tips

**Understand the Purpose:** The LOI is "the first stage in a two-stage process to receiving a PCORI funding award." It precedes full application submission.

**Follow Instructions Carefully:** "The best way to ensure your LOI is responsive is to carefully follow the instructions of the PFA." PFAs change between cycles, so use current versions only.

**Maximize Detail:** "You are encouraged to work with your team to describe all of the LOI components in as much detail as possible."

### What PCORI Does NOT Fund

- Instrument development/validation projects
- Cost-effectiveness analyses using quality-adjusted life-years
- Cost-focused comparisons as primary criteria
- Most projects lacking stakeholder involvement

---

## Source: PCORI Budgeting FAQs

**URL:** https://www.pcori.org/funding-opportunities/applicant-and-awardee-resources/frequently-asked-questions/budgeting-faqs
**Retrieved:** February 2, 2026

### Indirect Costs

- **Cap:** 40% of allowable direct costs
- **Exceptions:** Institutions without federally negotiated rates may request up to 10%
- **Exclusions:** Equipment, patient-related costs, and subcontractor costs over $25,000 are excluded from the indirect cost base
- **Rate Usage:** Must use negotiated rate if below 40%; cannot exceed 40% cap

### Personnel Costs

- **Salary Cap:** "$200,000 annual institutional base salary" per individual
- **Calculation Method:** Cap applies to base salary before calculating percentage effort
- **Fringe Benefits:** "No cap on the allowable fringe rate"
- **Students:** Salaries permitted; stipends are not allowable

### Equipment

Items exceeding $5,000 don't require pre-approval but must be budgeted with justification. Subject to PCORI review during budget assessment.

### Travel

Allowable when directly benefiting the project and consistent with institutional policy. Must follow "Uniform Guidance travel costs regulation (2 CFR 200.474)." Required conference travel specified in funding announcements.

### Other Notable Costs

- **DSMB Expenses:** Limited to 2% of total direct costs (exceeding requires director approval)
- **IRB Approval:** Allowable as direct cost with justification
- **Work Visas:** Unallowable
- **Patient Care:** Requests exceeding 15% of total research budget require strong justification
- **Per-Participant Costs:** Studies over approximately $40,000 per participant considered lower priority

### Subcontracts

First $25,000 of each subcontract's total costs eligible for prime applicant's indirect costs.

---

## Source: PCORI About Page

**URL:** https://www.pcori.org/about
**Retrieved:** February 2, 2026

### Mission and Vision

PCORI funds **patient-centered comparative clinical effectiveness research (CER)**, which compares benefits and potential harms of different healthcare options. The organization describes this approach as "Research Done Differently."

### Organizational History

- **Congressional Authorization:** 2010
- **Reauthorization:** December 2019 (expanded focus to intellectual/developmental disabilities and maternal morbidity/mortality)

### Total Funding Awarded

PCORI has funded **more than 2,400 research and related projects** since authorization.

### Research Priorities

Current focus areas include:
- Diabetes, obesity, cancer
- Maternal morbidity and mortality
- Intellectual and developmental disabilities
- Rare diseases and mental health

---

## Source: PCORI Executive Director Biography

**URL:** https://www.pcori.org/people/nakela-l-cook-md-mph
**Retrieved:** February 2, 2026

### Current Position

Executive Director at the Patient-Centered Outcomes Research Institute (PCORI)

### Educational Background

- Medical degree from Harvard Medical School
- Master of Public Health in health care policy and management from Harvard School of Public Health
- Clinical training completed at Massachusetts General Hospital in Boston

### Prior Professional Positions

- Senior Scientific Officer and Chief of Staff at the National Heart, Lung, and Blood Institute (NHLBI), the third largest institute within the National Institutes of Health

### Professional Focus Areas

- Cardiovascular disease and cardiology
- Health services research
- Reduction of health access and outcome disparities
- Patient engagement in research
- Precision medicine
- Data science
- Sickle cell disease
- Women's health

### Key Accomplishments

- Led "Pursuing Health Care Value Post-COVID-19: Keep The Focus on Patients" initiative
- Spearheaded NHLBI's strategic plan development and implementation
- Named among Modern Healthcare's "100 Most Influential People in Healthcare" for 2024
- Recipient of the 2020 Wenger Award for Excellence in Public Service from WomenHeart

---

## Source: PCORI Portfolio Explorer

**URL:** https://www.pcori.org/explore-our-portfolio
**Retrieved:** February 2, 2026

### Total Projects

The portfolio contains **2,621 funded projects and studies** currently displayed in the searchable database.

### Types of Research Funded

PCORI supports multiple funding categories:
- **Research:** 1,019 projects (including 85 conducted using PCORnet)
- **Engagement in Research:** 1,295 projects
- **Dissemination and Implementation:** 154 projects
- **Research Infrastructure:** 124 projects
- **Other Evidence Products:** 29 projects

### Project Status Distribution

- **Completed:** 1,922 projects
- **Ongoing:** 534 projects
- **In PCORI Peer Review:** 38 projects
- **Other (pending, terminated):** 127 projects

### Key Research Areas

Major health focus areas include:
- Mental/Behavioral Health: 414 projects
- Cancer: 223 projects
- Cardiovascular Diseases: 226 projects
- Respiratory Diseases: 171 projects
- Nutritional/Metabolic Disorders: 171 projects
- Neurological Disorders: 168 projects

### Geographic Distribution

The portfolio spans all 50 states, with highest concentrations in:
- California (290 projects)
- Massachusetts (245 projects)
- Pennsylvania (203 projects)
- Maryland (147 projects)

---

## Source: PCORI Methodology Standards

**URL:** https://www.pcori.org/research-related-projects/about-our-research/research-methodology/pcori-methodology-standards
**Retrieved:** February 2, 2026

### Total Standards

The Methodology Committee has created or endorsed **67 standards across 17 areas**.

### Cross-Cutting Standards (6 categories, 32 standards)

1. **Formulating Research Questions** - 5 standards (RQ-1 through RQ-6)
2. **Patient Centeredness** - 4 standards (PC-1 through PC-4)
3. **Data Integrity and Rigorous Analyses** - 7 standards (IR-1 through IR-7)
4. **Preventing and Handling Missing Data** - 4 standards (MD-1 through MD-4)
5. **Heterogeneity of Treatment Effects** - 3 standards (HT-1 through HT-3)
6. **Usual Care as Comparator** - 2 standards (UC-1 through UC-2)

### Design-Specific Standards (11 categories, 35 standards)

7. **Data Registries** - 4 standards (DR-1 through DR-4)
8. **Data Networks** - 2 standards (DN-1 through DN-2)
9. **Causal Inference Methods** - 6 standards (CI-1 through CI-6)
10. **Adaptive and Bayesian Trial Designs** - 4 standards (AT-1 through AT-4)
11. **Medical Tests** - 3 standards (MT-1 through MT-3)
12. **Systematic Reviews** - 1 standard (SR-1)
13. **Cluster-Based Research** - 5 standards (RC-1 through RC-5)
14. **Complex Interventions** - 5 standards (SCI-1 through SCI-5)
15. **Qualitative Methods** - 4 standards (QM-1 through QM-4)
16. **Mixed Methods Research** - 3 standards (MM-1 through MM-3)
17. **Individual Participant-Level Data Meta-Analysis** - 4 standards (IPD-1 through IPD-4)

### Key Requirements for Adherence

Research protocols must address study design, populations, outcomes, and analytical approaches with sufficient detail. Researchers should "develop a formal protocol that provides the plan for conducting the research" and register studies with appropriate registries.

Stakeholder engagement is mandatory: Include "individuals affected by the condition and...relevant stakeholders" in research processes, with documented justification if engagement is inappropriate.

---

## Source: Engagement Award: Capacity Building - Spring 2026 Cycle

**URL:** https://www.pcori.org/funding-opportunities/announcement/engagement-award-capacity-building-spring-2026-cycle
**Retrieved:** February 2, 2026

### Award Amounts

- **Total Available:** Up to $25 million in fiscal year 2026 across the Eugene Washington PCORI Engagement Award Program
- **Per Project Maximum:** "$300,000 in total costs" (direct + indirect combined)

### Duration Limits

- **Project Period:** Maximum two years
- **Earliest Start Date:** January 1, 2027

### Eligibility Requirements

**Funding Scope:** Projects must demonstrate capacity building for "patient-centered CER" (comparative clinical effectiveness research). Eligible projects:
- Build skills for patients, families, caregivers, and healthcare community members to engage as research partners
- Strengthen researcher partnerships with these groups
- Support prior awardees expanding impact

**Required Demonstrations:**
- Understanding of patient-centered CER basics
- Documented need for additional capacity building
- Pathway to future CER participation
- Commitment to generate and share learnings
- Organizational experience engaging target communities
- Patient/caregiver leadership throughout project

### Application Deadlines

| Phase | Date | Time |
|-------|------|------|
| Portal Opens | January 21, 2026 | 9 am ET |
| LOI Deadline | March 30, 2026 | 5 pm ET |
| LOI Status Notification | Within 60 calendar days | - |
| Full Proposal Deadline | July 13, 2026 | 5 pm ET |

### Required Components

**Full Proposal Must Include (if invited):**
- Biosketch template
- Two-year budget (Excel format)
- Budget justification
- Milestone/deliverable table
- Project workplan and timeline
- Letters of support table
- Board of directors information
- Demonstration of Foundational Expectations integration

---

## Source: PCORI 2025 Research Funding Cycle Announcement

**URL:** https://www.pcori.org/news-release/2024/pcori-opens-its-2025-research-funding-cycle-more-500-million-opportunities
**Retrieved:** February 2, 2026

### Funding Announcement

PCORI opened its 2025 research funding cycle with more than $500 million in opportunities, including:
- Up to $200 million through the Phased Large Awards for Comparative Clinical Effectiveness Research PFA
- Up to $160 million through the Broad Pragmatic Studies PFA
- Implementation projects (up to $23.5 million)
- Methods development for conducting CER (up to $12 million)
- Science of engagement in CER (up to $36 million)

### Cumulative Funding

Since 2010, PCORI has awarded more than $4.5 billion to fund patient-centered CER and research-related projects.

---

## Source: PCORI Health Equity and SDOH Research

**URL:** https://www.pcori.org/events/2023/how-pcori-advancing-social-determinants-health-data-collection-and-use-research-promote-health-equity
**Retrieved:** February 2, 2026

### Health Equity Focus

As a research funder, PCORI is guided by a National Priority to Achieve Health Equity, the goal of which is to expand engagement, research, research workforce, infrastructure, dissemination and implementation approaches that lead to continued progress toward achieving health equity in the United States.

### SDOH Data

A key component of health equity research is social determinants of health (SDOH) data, which capture context and concepts including social, economic, physical infrastructure, and education.

---

## Source: PCORI CHW and Patient Navigator Research

**URL:** https://www.pcori.org/funding-opportunities/announcement/broad-pragmatic-studies-funding-announcement-2024-standing-pfa-cycle-3-2024
**Retrieved:** February 2, 2026

### CHW/Patient Navigator Studies

Studies addressing the goal of Achieve Health Equity may include CHW and patient navigator interventions comparing:
- Different program models
- Worker functions
- Training and certification levels
- Implementation approaches across different settings, conditions, and populations

Studies may also examine various means of integrating CHW and patient navigators into the clinical care team to determine:
- Organizational strategies essential to redesigning teams
- Components required for well-functioning teams

---

*Document compiled: February 2, 2026*
*All content scraped directly from PCORI official website and related resources*
